Skip to content

Clinical trials

Phase 3 Candidiasis, Vulvovaginal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Candidiasis, Vulvovaginal Phase: Phase 3 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20081
20101
20131
20141
20171
20184
20194
20201
20211
20223
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Scynexis, Inc.5
Mycovia Pharmaceuticals Inc.3
Assiut University1
Avva Rus, JSC1
Bayer1
Ege University1
Indian Council of Medical Research1
Jiangsu HengRui Medicine Co., Ltd.1
Maastricht University Medical Center1
Medinova AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Candidiasis, Vulvovaginal21
Vaginosis, Bacterial3
Vaginitis2
Aspergillosis, Allergic Bronchopulmonary1
Blastomycosis1
Candidiasis1
Candidiasis, Chronic Mucocutaneous1
Candidiasis, Invasive1
Coccidioidomycosis1
Diabetes Mellitus1

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.